首页> 外文期刊>RSC Advances >A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies
【24h】

A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies

机译:一种简单的敏感UFLC-MS / MS / MS方法,用于同时定量野石素,二氢氨基氨基素和槲皮素在大鼠等离子体中的应用及其对药代动力学研究的应用

获取原文
获取原文并翻译 | 示例
           

摘要

An ultrafast liquid chromatography-tandem mass spectrometry (UFLC-MS/MS) method was developed for the simultaneous estimation of artesunate (ART), dihydroartemisinin (DHA, an active metabolite of ART) and quercetin (QRT) in rat plasma. The separation was achieved using a Zorbax C-18 column (3 mu m, 50 mm x 4.6 mm) as a stationary phase with a mobile phase of 0.1% formic acid (10% by volume) and methanol (90% by volume) at a flow rate of 0.4 mL min(-1) and an injection volume of 10 mu L. Artemisinin (ATM) was used as the internal standard (IS). Mass detection was performed by electrospray ionization (ESI)-tandem mass spectrometry via multiple reaction monitoring (MRM) in positive mode except for QRT, where negative ionization was used. The extraction recoveries of ART, DHA, and QRT from plasma were found to be 91.05-99.62%, 95.12-98.56% and 89.35-98.90%, respectively. The developed method was validated and successfully applied to the quantitative analysis of ART, DHA and QRT in plasma samples after the oral administration of ART and ART-QRT pure drugs to rats at the dose of 5 mg kg(-1) each. The results reveal that the developed method can be further used for the quantification of the proposed combination drugs in nanoformulations.
机译:开发了超快液相色谱 - 串联质谱(UFLC-MS / MS)方法,用于同时估计艺术昆酸(ART),二氢雄氨酸(DHA,ART)和大鼠等离子体槲皮素(QRT)的槲皮素(DHA,QRT)。使用ZORBAX C-18柱(3μm,50mm×4.6mm)作为固定相的分离,其流动阶段为0.1%甲酸(10重量%)和甲醇(90体积%)使用0.4mL min(-1)的流速和10μmL.Artemisinin(ATM)的注射体积作为内标(是)。通过电喷雾电离(ESI) - 通过多种反应监测(MRM)以QRT以QRT的多种反应监测(MRM)进行质谱,除了使用负电离。血浆中的ART,DHA和QRT的提取回收率分别为91.05-99.62%,95.12-98.56%和89.35-98.90%。经过验证并成功地验证了开发的方法,并成功地应用于血浆样品中的血浆样品中的艺术,DHA和QRT的定量分析,并且在每种剂量为5mg kg(-1)的大鼠中。结果表明,开发方法可以进一步用于纳米族种类中所提出的组合药物的定量。

著录项

  • 来源
    《RSC Advances》 |2019年第71期|共9页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号